Interaction magnitude, pharmacokinetics and pharmacodynamics of ticlopidine in relation to CYP2C19 genotypic statusIEIRI, Ichiro; KIMURA, Miyuki; IRIE, Shin et al.Pharmacogenetics and genomics (Print). 2005, Vol 15, Num 12, pp 851-859, issn 1744-6872, 9 p.Article

Hépatite granulomateuse et ticopidine = Granulomatous hepatitis and ticlopidineFLAMENBAUM, M; ZENUT, M; CASTILLO, D et al.Thérapie (Paris). 1997, Vol 52, Num 6, pp 610-611, issn 0040-5957Article

Poor responsiveness to clopidogrel : Drug-specific or class-effect mechanism? evidence from a clopidogrel-to-ticlopidine crossover studyCAMPO, Gianluca; VALGIMIGLI, Marco; PARRINELLO, Giovanni et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 12, pp 1132-1137, issn 0735-1097, 6 p.Article

Effects of policosanol and ticlopidine in patients with intermittent claudication: A double-blinded pilot comparative studyCASTANO, Gladys; MAS, Rosa; GAMEZ, Rafael et al.Angiology. 2004, Vol 55, Num 4, pp 361-371, issn 0003-3197, 11 p.Article

Probable interaction between cyclosporin A and low dose ticlopidineVERDEJO, A; DE COS, M. A; ZUBIMENDI, J. A et al.BMJ. British medical journal (International ed.). 2000, Vol 320, Num 7241, issn 0959-8146, p. 1037Article

Liquid chromatographic method for the determination of ticlopidine in human plasmaRONA, K; ARY, K; GACHALYI, B et al.Journal of chromatography. B, Biomedical sciences and applications. 1997, Vol 693, Num 2, pp 393-398, issn 1387-2273Article

New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?BLACK, Corrinda; PATERSON, Kenneth R.Adverse drug reactions and toxicological reviews. 2001, Vol 20, Num 4, pp 277-303, issn 0964-198XArticle

Unusual effects of aspirin on ticlopidine induced thrombolysisGRYGLEWSKI, R. J; URACZ, W; SWIGS, J et al.Thorax. 2000, Vol 55, pp S17-S19, issn 0040-6376, SUP2Conference Paper

A Critical Appraisal of the Functional Evolution of P2Y12 Antagonists as Antiplatelet DrugsFAYAZ, S. M. A; RAJANIKANT, G. K.Current pharmaceutical design (Print). 2012, Vol 18, Num 12, pp 1625-1634, issn 1381-6128, 10 p.Article

Comparison of In Vitro Metabolism of Ticlopidine by Human Cytochrome P450 2B6 and Rabbit Cytochrome P450 2B4TALAKAD, Jyothi C; SHAH, Manish B; WALKER, Gregory S et al.Drug metabolism and disposition. 2011, Vol 39, Num 3, pp 539-550, issn 0090-9556, 12 p.Article

Ticlopidine-induced hepatotoxicity in a GSH-depleted rat modelSHIMIZU, Shinji; ATSUMI, Ryo; NAKAZAWA, Tsunenori et al.Archives of toxicology. 2011, Vol 85, Num 4, pp 347-353, issn 0340-5761, 7 p.Article

Determination of Ticlopidine in Pharmaceutical Tablets by Flow Injection Analysis Using UV-DetectionCAN, Nafiz O; ALTIOKKA, Göksel; ABOUL-ENEIN, Hassan Y et al.Journal of liquid chromatography & related technologies. 2008, Vol 31, Num 17-20, pp 3209-3218, issn 1082-6076, 10 p.Article

Non-bleeding side effects of clopidogrel : Have large multi-center clinical trials underestimated their incidence?ALMSHERQI, Zakaria A; MCLACHLAN, Craig S; SHAREF, Sadik M et al.International journal of cardiology. 2007, Vol 117, Num 3, pp 415-417, issn 0167-5273, 3 p.Article

Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylationTURPEINEN, Miia; TOLONEN, Ari; UUSITALO, Jouko et al.Clinical pharmacology and therapeutics. 2005, Vol 77, Num 6, pp 553-559, issn 0009-9236, 7 p.Article

Clopidogrel and ticlopidine: P2Y₁₂ adenosine diphosphate-receptor antagonists for the prevention of atherothrombosisSAVI, Pierre; HERBERT, Jean-Marc.Seminars in thrombosis and hemostasis. 2005, Vol 31, Num 2, pp 174-183, issn 0094-6176, 10 p.Article

Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetesNOMURA, Shosaku; TAKAHASHI, Nobuyuki; INAMI, Norihito et al.Atherosclerosis. 2004, Vol 174, Num 2, pp 329-335, issn 0021-9150, 7 p.Article

Antiplatelet strategiesPATRONO, C.European heart journal supplements. 2002, Vol 4, Num A, pp A42-A47, issn 1520-765XArticle

A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: A report of two new cases of ticlopidine-induced hepatotoxicityZAPATER, Pedro; SUCH, José; PEREZ-MATEO, Miguel et al.Drug safety. 2002, Vol 25, Num 10, pp 735-750, issn 0114-5916, 16 p.Article

The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicineDAVIS, Mellar P; HOMSI, Jade.Supportive care in cancer. 2001, Vol 9, Num 6, pp 442-451, issn 0941-4355Article

Significance of chemokines and activated platelets in patients with diabetesNOMURA, S; SHOUZU, A; OMOTO, S et al.Clinical and experimental immunology (Print). 2000, Vol 121, Num 3, pp 437-443, issn 0009-9104Article

Stroke prevention : Antiplatelet and antithrombolytic therapyDIENER, H.-C.Neurologic clinics. 2000, Vol 18, Num 2, issn 0733-8619, vi, 343-355 [14 p.]Article

Consider this : It's too little!BLOCK, P. C.Catheterization and cardiovascular interventions. 2000, Vol 50, Num 3, pp 280-281, issn 1522-1946Article

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS)BERTRAND, M. E; RUPPRECHT, H.-J; URBAN, P et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 6, pp 624-629, issn 0009-7322Article

Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidineDILLON, W. C; ECKERT, G. J; DILLON, J. C et al.Catheterization and cardiovascular interventions. 2000, Vol 50, Num 4, pp 426-430, issn 1522-1946Article

Médicaments inhibiteurs des fonctions plaquettaires = Antiplatelet drugsLECOMPTE, Thomas; FERRARI, Emile; NGUYEN, Philippe et al.STV. Sang thrombose vaisseaux. 2000, Vol 12, pp 3-11, issn 0999-7385, NSArticle